{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:55:59Z","timestamp":1791352559429,"version":"4.3.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,10,3]],"date-time":"2008-10-03T00:00:00Z","timestamp":1222992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2008,10,3]],"date-time":"2008-10-03T00:00:00Z","timestamp":1222992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Bone marrow oedema (BME) and avascular osteonecrosis (AVN) are disorders of unclear origin. Although there are numerous operative and non-operative treatments for AVN, pain management in patients with AVN remains challenging. Prostaglandins play an important role in inflammatory responses and cell differentiation. It is thought that prostaglandin I<jats:sub>2<\/jats:sub> ([PGI<jats:sub>2<\/jats:sub>] or synonoma prostacyclin) and its analogues promote bone regeneration on a cellular or systemic level. The purpose of this study was to assess the curative and symptomatic efficacy of the prostacyclin analogue iloprost in BME and AVN patients.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Method<\/jats:title>\n                        <jats:p>We are reporting on 50 patients (117 bones) affected by BME\/AVN who were treated with iloprost. Pain levels before, during and 3 and 6 months after iloprost application were evaluated by a visual analogue scale (VAS). The short form(SF)-36 health survey served to judge general health status before and after treatment. Harris Hip Score (HHS) and Knee Society Score (KSS) were performed as functional scores and MRI and X-rays before and 3 and 6 months after iloprost application served as objective parameters for morphological changes of the affected bones.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>We found a significant improvement in pain, functional and radiological outcome in BME and early AVN stages after iloprost application, whereas patients with advanced AVN stages did not benefit from iloprost infusions. Mean pain level decreased from 5.26 (day 0) to 1.63 (6 months) and both HHS and KSS increased during follow-up. Moreover, the SF-36 increased from 353.2 (day 0) to 560.5 points (6 months). We found a significant decrease in BME on MRI scans after iloprost application.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>In addition to other drugs, iloprost may be an alternative substance which should be considered in the treatment of BME\/AVN-associated pain.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar2526","type":"journal-article","created":{"date-parts":[[2008,10,3]],"date-time":"2008-10-03T18:14:26Z","timestamp":1223057666000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Rationale for prostaglandin I2in bone marrow oedema \u2013 from theory to application"],"prefix":"10.1186","volume":"10","author":[{"given":"Marcus","family":"J\u00e4ger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Peter","family":"Tillmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S","family":"Thornhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Blondin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd R\u00fcdiger","family":"Hetzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Zilkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"Krauspe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,10,3]]},"reference":[{"issue":"Suppl","key":"2375_CR1","doi-asserted-by":"publisher","first-page":"S314","DOI":"10.1097\/00003086-199810001-00032","volume":"355","author":"MA Mont","year":"1998","unstructured":"Mont MA, Jones LC, Einhorn TA, Hungerford DS, Reddi AH: Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors. Clin Orthop Relat Res. 1998, 355 (Suppl): S314-335. 10.1097\/00003086-199810001-00032.","journal-title":"Clin Orthop Relat Res"},{"key":"2375_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.orthres.2003.10.002","volume":"22","author":"W Drescher","year":"2004","unstructured":"Drescher W, Weigert KP, Bunger MH, Ingerslev J, Bunger C, Hansen ES: Femoral head blood flow reduction and hypercoagulability under 24 h megadose steroid treatment in pigs. J Orthop Res. 2004, 22: 501-508. 10.1016\/j.orthres.2003.10.002.","journal-title":"J Orthop Res"},{"key":"2375_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/01.TP.0000043926.74349.6D","volume":"75","author":"JG Heaf","year":"2003","unstructured":"Heaf JG: Bone disease after renal transplantation. Transplantation. 2003, 75: 315-325. 10.1097\/01.TP.0000043926.74349.6D.","journal-title":"Transplantation"},{"key":"2375_CR4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00776-003-0716-9","volume":"8","author":"S Inoue","year":"2003","unstructured":"Inoue S, Horii M, Asano T, Fujioka M, Ogura T, Shibatani M, Kim WC, Nakagawa M, Tanaka T, Hirota Y, Kubo T: Risk factors for nontraumatic osteonecrosis of the femoral head after renal transplantation. J Orthop Sci. 2003, 8: 751-756. 10.1007\/s00776-003-0716-9.","journal-title":"J Orthop Sci"},{"key":"2375_CR5","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1056\/NEJM199603213341203","volume":"334","author":"M den Heijer","year":"1996","unstructured":"den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR: Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996, 334: 759-762. 10.1056\/NEJM199603213341203.","journal-title":"N Engl J Med"},{"key":"2375_CR6","first-page":"783","volume":"30","author":"LC Jones","year":"2003","unstructured":"Jones LC, Mont MA, Le TB, Petri M, Hungerford DS, Wang P, Glueck CJ: Procoagulants and osteonecrosis. J Rheumatol. 2003, 30: 783-791.","journal-title":"J Rheumatol"},{"key":"2375_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7326\/0003-4819-137-1-200207020-00008","volume":"137","author":"KD Miller","year":"2002","unstructured":"Miller KD, Masur H, Jones EC, Joe GO, Rick ME, Kelly GG, Mican JM, Liu S, Gerber LH, Blackwelder WC, Falloon J, Davey RT, Polis MA, Walker RE, Lane HC, Kovacs JA: High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med. 2002, 137: 17-25.","journal-title":"Ann Intern Med"},{"key":"2375_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/00126334-200009010-00003","volume":"25","author":"AN Scribner","year":"2000","unstructured":"Scribner AN, Troia-Cancio PV, Cox BA, Marcantonio D, Hamid F, Keiser P, Levi M, Allen B, Murphy K, Jones RE, Skiest DJ: Osteonecrosis in HIV: a case-control study. J Acquir Immune Defic Syndr. 2000, 25: 19-25. 10.1097\/00042560-200009010-00003.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 1","key":"2375_CR9","doi-asserted-by":"publisher","first-page":"A2","DOI":"10.1259\/bjr.75.suppl_1.750002","volume":"75","author":"RJ Wenstrup","year":"2002","unstructured":"Wenstrup RJ, Roca-Espiau M, Weinreb NJ, Bembi B: Skeletal aspects of Gaucher disease: a review. Br J Radiol. 2002, 75 (Suppl 1): A2-12.","journal-title":"Br J Radiol"},{"key":"2375_CR10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00003086-198005000-00023","volume":"148","author":"DB Miskew","year":"1980","unstructured":"Miskew DB, Goldflies ML: Atraumatic avascular necrosis of the talus associated with hyperuricemia. Clin Orthop Relat Res. 1980, 148: 156-159.","journal-title":"Clin Orthop Relat Res"},{"key":"2375_CR11","first-page":"609","volume":"26","author":"JT Moskal","year":"1997","unstructured":"Moskal JT, Topping RE, Franklin LL: Hypercholesterolemia: an association with osteonecrosis of the femoral head. Am J Orthop. 1997, 26: 609-612.","journal-title":"Am J Orthop"},{"key":"2375_CR12","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2106\/00004623-200303000-00016","volume":"85-A","author":"P Hernigou","year":"2003","unstructured":"Hernigou P, Bachir D, Galacteros F: The natural history of symptomatic osteonecrosis in adults with sickle-cell disease. J Bone Joint Surg Am. 2003, 85-A: 500-504.","journal-title":"J Bone Joint Surg Am"},{"key":"2375_CR13","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3346\/jkms.2002.17.6.806","volume":"17","author":"J Park","year":"2002","unstructured":"Park J, Jun J, Kim Y, Lee J, Kim C, Hahn S: Osteonecrosis of the hip in patients with aplastic anemia. J Korean Med Sci. 2002, 17: 806-810.","journal-title":"J Korean Med Sci"},{"key":"2375_CR14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s00393-003-0473-3","volume":"62","author":"M J\u00e4ger","year":"2003","unstructured":"J\u00e4ger M, Thorey F, Wild A, Voede M, Krauspe R: Osteonecrosis of Behcet's disease: diagnosis, therapy, and course. Z Rheumatol. 2003, 62: 390-394. 10.1007\/s00393-003-0473-3.","journal-title":"Z Rheumatol"},{"key":"2375_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1359\/JBMR.0301250","volume":"19","author":"MJ Bolland","year":"2004","unstructured":"Bolland MJ, Hood G, Bastin ST, King AR, Grey A: Bilateral femoral head osteonecrosis after septic shock and multiorgan failure. J Bone Miner Res. 2004, 19: 517-520. 10.1359\/JBMR.0301250.","journal-title":"J Bone Miner Res"},{"key":"2375_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s002640050335","volume":"23","author":"HG Simank","year":"1999","unstructured":"Simank HG, Brocai DR, Strauch K, Lukoschek M: Core decompression in osteonecrosis of the femoral head: risk-factor-dependent outcome evaluation using survivorship analysis. Int Orthop. 1999, 23: 154-159. 10.1007\/s002640050335.","journal-title":"Int Orthop"},{"key":"2375_CR17","first-page":"41","volume":"54","author":"E Scotter","year":"1988","unstructured":"Scotter E, Moody A: Dysbaric osteonecrosis (caisson disease). Radiogr Today. 1988, 54: 41-43.","journal-title":"Radiogr Today"},{"key":"2375_CR18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1055\/s-2003-45495","volume":"215","author":"A Werner","year":"2003","unstructured":"Werner A, Jager M, Schmitz H, Krauspe R: Joint preserving surgery for osteonecrosis and osteochondral defects after chemotherapy in childhood. Klin Padiatr. 2003, 215: 332-337. 10.1055\/s-2003-45495.","journal-title":"Klin Padiatr"},{"key":"2375_CR19","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2214\/AJR.05.0086","volume":"186","author":"H Ito","year":"2006","unstructured":"Ito H, Matsuno T, Minami A: Relationship between bone marrow edema and development of symptoms in patients with osteonecrosis of the femoral head. AJR Am J Roentgenol. 2006, 186: 1761-1770. 10.2214\/AJR.05.0086.","journal-title":"AJR Am J Roentgenol"},{"key":"2375_CR20","first-page":"405","volume":"23","author":"GG Gallant","year":"1994","unstructured":"Gallant GG, Fisher RL, Sziklas JJ: Transient regional osteoporosis of the ankle and foot. A report of four cases and review of the literature. Orthop Rev. 1994, 23: 405-409.","journal-title":"Orthop Rev"},{"key":"2375_CR21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1302\/0301-620X.75B2.8444939","volume":"75","author":"S Hofmann","year":"1993","unstructured":"Hofmann S, Engel A, Neuhold A, Leder K, Kramer J, Plenk H: Bone-marrow oedema syndrome and transient osteoporosis of the hip. An MRI-controlled study of treatment by core decompression. J Bone Joint Surg Br. 1993, 75: 210-216.","journal-title":"J Bone Joint Surg Br"},{"key":"2375_CR22","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1302\/0301-620X.82B6.10740","volume":"82","author":"YM Kim","year":"2000","unstructured":"Kim YM, Oh HC, Kim HJ: The pattern of bone marrow oedema on MRI in osteonecrosis of the femoral head. J Bone Joint Surg Br. 2000, 82: 837-841. 10.1302\/0301-620X.82B6.10740.","journal-title":"J Bone Joint Surg Br"},{"key":"2375_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/00003086-199701000-00010","volume":"334","author":"H Plenk Jr","year":"1997","unstructured":"Plenk H, Hofmann S, Eschberger J, Gstettner M, Kramer J, Schneider W, Engel A: Histomorphology and bone morphometry of the bone marrow edema syndrome of the hip. Clin Orthop Relat Res. 1997, 334: 73-84. 10.1097\/00003086-199701000-00010.","journal-title":"Clin Orthop Relat Res"},{"key":"2375_CR24","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1302\/0301-620X.76B6.7983140","volume":"76","author":"P Doury","year":"1994","unstructured":"Doury P: Bone-marrow oedema, transient osteoporosis, and algodystrophy. J Bone Joint Surg Br. 1994, 76: 993-994.","journal-title":"J Bone Joint Surg Br"},{"key":"2375_CR25","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1148\/radiology.212.2.r99au03527","volume":"212","author":"BC Vande Berg","year":"1999","unstructured":"Vande Berg BC, Malghem JJ, Lecouvet FE, Jamart J, Maldague BE: Idiopathic bone marrow edema lesions of the femoral head: predictive value of MR imaging findings. Radiology. 1999, 212: 527-535.","journal-title":"Radiology"},{"key":"2375_CR26","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.crad.2004.04.014","volume":"59","author":"A Saini","year":"2004","unstructured":"Saini A, Saifuddin A: MRI of osteonecrosis. Clin Radiol. 2004, 59: 1079-1093. 10.1016\/j.crad.2004.04.014.","journal-title":"Clin Radiol"},{"key":"2375_CR27","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1148\/radiology.161.3.3786725","volume":"161","author":"DG Mitchell","year":"1986","unstructured":"Mitchell DG, Kressel HY, Arger PH, Dalinka M, Spritzer CE, Steinberg ME: Avascular necrosis of the femoral head: morphologic assessment by MR imaging, with CT correlation. Radiology. 1986, 161: 739-742.","journal-title":"Radiology"},{"key":"2375_CR28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00003086-198907000-00007","volume":"244","author":"DG Mitchell","year":"1989","unstructured":"Mitchell DG, Steinberg ME, Dalinka MK, Rao VM, Fallon M, Kressel HY: Magnetic resonance imaging of the ischemic hip. Alterations within the osteonecrotic, viable, and reactive zones. Clin Orthop Relat Res. 1989, 244: 60-77.","journal-title":"Clin Orthop Relat Res"},{"key":"2375_CR29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2106\/00004623-199503000-00018","volume":"77","author":"MA Mont","year":"1995","unstructured":"Mont MA, Hungerford DS: Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. 1995, 77: 459-474.","journal-title":"J Bone Joint Surg Am"},{"key":"2375_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00132-005-0762-4","volume":"34","author":"S Hofmann","year":"2005","unstructured":"Hofmann S, Kramer J, Plenk H: Osteonecrosis of the hip in adults. Orthopade. 2005, 34: 171-183. 10.1007\/s00132-005-0762-4.","journal-title":"Orthopade"},{"key":"2375_CR31","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1083-7515(03)00145-1","volume":"8","author":"N Aigner","year":"2003","unstructured":"Aigner N, Meizer R, Stolz G, Petje G, Krasny C, Landsiedl F, Steinboeck G: Iloprost for the treatment of bone marrow edema in the hindfoot. Foot Ankle Clin. 2003, 8: 683-693. 10.1016\/S1083-7515(03)00145-1.","journal-title":"Foot Ankle Clin"},{"key":"2375_CR32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s00508-005-321-3","volume":"117","author":"N Aigner","year":"2005","unstructured":"Aigner N, Petje G, Schneider W, Meizer R, Wlk M, Kotsaris S, Knahr K, Landsiedl F: Bone marrow edema syndrome of the femoral head: treatment with the prostacyclin analogue iloprost vs. core decompression: an MRI-controlled study. Wien Klin Wochenschr. 2005, 117: 130-135. 10.1007\/s00508-005-321-3.","journal-title":"Wien Klin Wochenschr"},{"key":"2375_CR33","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1302\/0301-620X.83B6.11377","volume":"83","author":"N Aigner","year":"2001","unstructured":"Aigner N, Petje G, Steinboeck G, Schneider W, Krasny C, Landsiedl F: Treatment of bone-marrow oedema of the talus with the prostacyclin analogue iloprost. An MRI-controlled investigation of a new method. J Bone Joint Surg Br. 2001, 83: 855-858. 10.1302\/0301-620X.83B6.11377.","journal-title":"J Bone Joint Surg Br"},{"key":"2375_CR34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/107110070202300513","volume":"23","author":"N Aigner","year":"2002","unstructured":"Aigner N, Petje G, Steinboeck G, Schneider W, Krasny C, Landsiedl F: Bone marrow edema of the forefoot after chevron osteotomy \u2013 a rare cause of metatarsalgia: a case report. Foot Ankle Int. 2002, 23: 447-451.","journal-title":"Foot Ankle Int"},{"key":"2375_CR35","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1302\/0301-620X.87B4.15658","volume":"87","author":"AC Disch","year":"2005","unstructured":"Disch AC, Matziolis G, Perka C: The management of necrosis-associated and idiopathic bone-marrow oedema of the proximal femur by intravenous iloprost. J Bone Joint Surg Br. 2005, 87: 560-564. 10.1302\/0301-620X.87B4.15658.","journal-title":"J Bone Joint Surg Br"},{"key":"2375_CR36","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1055\/s-0037-1614202","volume":"91","author":"AC Disch","year":"2004","unstructured":"Disch AC, Matziolis G, Reinke P, Perka C: Intravenous Iloprost treatment for severe bone pain caused by sickle cell crisis. Thromb Haemost. 2004, 91: 1047-1049.","journal-title":"Thromb Haemost"},{"key":"2375_CR37","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s00508-005-0326-y","volume":"117","author":"R Meizer","year":"2005","unstructured":"Meizer R, Radda C, Stolz G, Kotsaris S, Petje G, Krasny C, Wlk M, Mayerhofer M, Landsiedl F, Aigner N: MRI-controlled analysis of 104 patients with painful bone marrow edema in different joint localizations treated with the prostacyclin analogue iloprost. Wien Klin Wochenschr. 2005, 117: 278-286. 10.1007\/s00508-005-0326-y.","journal-title":"Wien Klin Wochenschr"},{"key":"2375_CR38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00482-004-0356-9","volume":"18","author":"M J\u00e4ger","year":"2004","unstructured":"J\u00e4ger M, Werner A, Lentrodt S, M\u00f6dder U, Krauspe R: Pain management in non-juvenile, aseptic osteonecrosis. Schmerz. 2004, 18: 481-491. 10.1007\/s00482-004-0356-9.","journal-title":"Schmerz"},{"key":"2375_CR39","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1600-6143.2007.01662.x","volume":"7","author":"FP Tillmann","year":"2007","unstructured":"Tillmann FP, J\u00e4ger M, Blondin D, Schooldermann D, Voiculescu A, Sucker C, Grabensee B, Krauspe R, Hetzel GR: Intravenous iloprost: a new therapeutic option for patients with post-transplant distal limb syndrome (PTDLS). Am J Transplant. 2007, 7: 667-671. 10.1111\/j.1600-6143.2007.01662.x.","journal-title":"Am J Transplant"},{"key":"2375_CR40","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1517\/14656566.6.11.1921","volume":"6","author":"HH Hsu","year":"2005","unstructured":"Hsu HH, Rubin LJ: Iloprost inhalation solution for the treatment of pulmonary arterial hypertension. Expert Opin Pharmacother. 2005, 6: 1921-1930. 10.1517\/14656566.6.11.1921.","journal-title":"Expert Opin Pharmacother"},{"key":"2375_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1365-2230.2004.01529.x","volume":"29","author":"C Foti","year":"2004","unstructured":"Foti C, Cassano N, Conserva A, Coviello C, De Meo M, Vena GA: Diffuse cutaneous systemic sclerosis treated with intravenous iloprost. Clin Exp Dermatol. 2004, 29: 321-323. 10.1111\/j.1365-2230.2004.01529.x.","journal-title":"Clin Exp Dermatol"},{"key":"2375_CR42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/03009740310004711","volume":"33","author":"B Marasini","year":"2004","unstructured":"Marasini B, Massarotti M, Bottasso B, Coppola R, Papa ND, Maglione W, Comina DP, Maioli C: Comparison between iloprost and alprostadil in the treatment of Raynaud's phenomenon. Scand J Rheumatol. 2004, 33: 253-256. 10.1080\/03009740310004711.","journal-title":"Scand J Rheumatol"},{"key":"2375_CR43","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1191\/0961203302lu137cr","volume":"11","author":"A Mathieu","year":"2002","unstructured":"Mathieu A, Sanna G, Mameli A, Pinna C, Vacca A, Cauli A, Passiu G, Piga M: Sustained normalization of cerebral blood-flow after iloprost therapy in a patient with neuropsychiatric systemic lupus erythematosus. Lupus. 2002, 11: 52-56. 10.1191\/0961203302lu137cr.","journal-title":"Lupus"},{"key":"2375_CR44","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/00007890-199908150-00005","volume":"68","author":"KK Changani","year":"1999","unstructured":"Changani KK, Fuller BJ, Bell JD, Taylor-Robinson SD, Moore DP, Davidson BR: Improved preservation solutions for organ storage: a dynamic study of hepatic metabolism. Transplantation. 1999, 68: 345-355. 10.1097\/00007890-199908150-00005.","journal-title":"Transplantation"},{"key":"2375_CR45","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jtcvs.2004.04.040","volume":"129","author":"B Gohrbandt","year":"2005","unstructured":"Gohrbandt B, Sommer SP, Fischer S, Hohlfeld JM, Warnecke G, Haverich A, Strueber M: Iloprost to improve surfactant function in porcine pulmonary grafts stored for twenty-four hours in low-potassium dextran solution. J Thorac Cardiovasc Surg. 2005, 129: 80-86. 10.1016\/j.jtcvs.2004.04.040.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2375_CR46","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0895-4356(98)00081-X","volume":"51","author":"JE Ware Jr","year":"1998","unstructured":"Ware JE, Gandek B: Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol. 1998, 51: 903-912. 10.1016\/S0895-4356(98)00081-X.","journal-title":"J Clin Epidemiol"},{"key":"2375_CR47","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/ndt\/15.11.1859","volume":"15","author":"GR Hetzel","year":"2000","unstructured":"Hetzel GR, Malms J, May P, Heering P, Voiculescu A, Modder U, Grabensee B: Post-transplant distal-limb bone-marrow oedema: MR imaging and therapeutic considerations. Nephrol Dial Transplant. 2000, 15: 1859-1864. 10.1093\/ndt\/15.11.1859.","journal-title":"Nephrol Dial Transplant"},{"key":"2375_CR48","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/rheumatology\/kem172","volume":"46","author":"ME Mayerhoefer","year":"2007","unstructured":"Mayerhoefer ME, Kramer J, Breitenseher MJ, Norden C, Vakil-Adli A, Hofmann S, Meizer R, Siedentop H, Landsiedl F, Aigner N: Short-term outcome of painful bone marrow oedema of the knee following oral treatment with iloprost or tramadol: results of an exploratory phase II study of 41 patients. Rheumatology (Oxford). 2007, 46: 1460-1465. 10.1093\/rheumatology\/kem172.","journal-title":"Rheumatology (Oxford)"},{"key":"2375_CR49","first-page":"197","volume":"56","author":"MA Mont","year":"2007","unstructured":"Mont MA, Jones LC, Seyler TM, Marulanda GA, Saleh KJ, Delanois RE: New treatment approaches for osteonecrosis of the femoral head: an overview. Instr Course Lect. 2007, 56: 197-212.","journal-title":"Instr Course Lect"},{"key":"2375_CR50","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/00003086-200408000-00021","volume":"425","author":"CJ Belmar","year":"2004","unstructured":"Belmar CJ, Steinberg ME, Hartman-Sloan KM: Does pain predict outcome in hips with osteonecrosis?. Clin Orthop Relat Res. 2004, 425: 158-162. 10.1097\/00003086-200408000-00021.","journal-title":"Clin Orthop Relat Res"},{"key":"2375_CR51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00402-003-0506-z","volume":"123","author":"S Radke","year":"2003","unstructured":"Radke S, Rader C, Kenn W, Kirschner S, Walther M, Eulert J: Transient marrow edema syndrome of the hip: results after core decompression. A prospective MRI-controlled study in 22 patients. Arch Orthop Trauma Surg. 2003, 123: 223-227.","journal-title":"Arch Orthop Trauma Surg"},{"key":"2375_CR52","first-page":"389","volume":"29","author":"H Plenk Jr","year":"2000","unstructured":"Plenk H, Hofmann S, Breitenseher M, Urban M: Pathomorphological aspects and repair mechanisms of femur head necrosis. Orthopade. 2000, 29: 389-402.","journal-title":"Orthopade"},{"key":"2375_CR53","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.2106\/JBJS.E.00174","volume":"87","author":"CJ Wang","year":"2005","unstructured":"Wang CJ, Wang FS, Huang CC, Yang KD, Weng LH, Huang HY: Treatment for osteonecrosis of the femoral head: comparison of extracorporeal shock waves with core decompression and bone-grafting. J Bone Joint Surg Am. 2005, 87: 2380-2387. 10.2106\/JBJS.E.00174.","journal-title":"J Bone Joint Surg Am"},{"key":"2375_CR54","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1302\/0301-620X.84B5.12282","volume":"84","author":"HB Durst","year":"2002","unstructured":"Durst HB, Blatter G, Kuster MS: Osteonecrosis of the humeral head after extracorporeal shock-wave lithotripsy. J Bone Joint Surg Br. 2002, 84: 744-746. 10.1302\/0301-620X.84B5.12282.","journal-title":"J Bone Joint Surg Br"},{"key":"2375_CR55","first-page":"133","volume":"6","author":"F Rodola","year":"2002","unstructured":"Rodola F, Conti C, Abballe C, Chierichini A, Ciano F, Forte E, Iacobucci T, Sorrentino L, Vagnoni S, Vergari A, D'Avolio S: Anaesthesia for shock wave therapy in musculoskeletal disorders: a preliminary report. Eur Rev Med Pharmacol Sci. 2002, 6: 133-138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2375_CR56","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2165\/00003495-199243060-00008","volume":"43","author":"SM Grant","year":"1992","unstructured":"Grant SM, Goa KL: Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures. Drugs. 1992, 43: 889-924. 10.2165\/00003495-199243060-00008.","journal-title":"Drugs"},{"key":"2375_CR57","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0952-3278(94)90103-1","volume":"50","author":"AO Aktan","year":"1994","unstructured":"Aktan AO, Buyukgebiz O, Yegen C, Yalcin SH, Haklar G, Yalin R, Ercan S: Does PGE2 act as a mediator for endothelin release?. Prostaglandins Leukot Essent Fatty Acids. 1994, 50: 37-41. 10.1016\/0952-3278(94)90103-1.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2375_CR58","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/BF02576396","volume":"194","author":"O Buyukgebiz","year":"1994","unstructured":"Buyukgebiz O, Aktan AO, Yegen C, Yalcin AS, Haklar G, Yalin R, Ercan ZS: Captopril increases endothelin serum concentrations and preserves intestinal mucosa after mesenteric ischemia-reperfusion injury. Res Exp Med (Berl). 1994, 194: 339-348. 10.1007\/BF02576396.","journal-title":"Res Exp Med (Berl)"},{"key":"2375_CR59","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0090-6980(91)90028-E","volume":"41","author":"M Erlansson","year":"1991","unstructured":"Erlansson M, Bergqvist D, Persson NH, Svensjo E: Modification of postischemic increase of leukocyte adhesion and vascular permeability in the hamster by Iloprost. Prostaglandins. 1991, 41: 157-168. 10.1016\/0090-6980(91)90028-E.","journal-title":"Prostaglandins"},{"key":"2375_CR60","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/BF00914313","volume":"13","author":"M Erlansson","year":"1989","unstructured":"Erlansson M, Svensjo E, Bergqvist D: Leukotriene B4-induced permeability increase in postcapillary venules and its inhibition by three different antiinflammatory drugs. Inflammation. 1989, 13: 693-705. 10.1007\/BF00914313.","journal-title":"Inflammation"},{"key":"2375_CR61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejphar.2004.04.041","volume":"494","author":"V Giguere","year":"2004","unstructured":"Giguere V, Gallant MA, de Brum-Fernandes AJ, Parent JL: Role of extracellular cysteine residues in dimerization\/oligomerization of the human prostacyclin receptor. Eur J Pharmacol. 2004, 494: 11-22. 10.1016\/j.ejphar.2004.04.041.","journal-title":"Eur J Pharmacol"},{"key":"2375_CR62","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1054\/plef.2001.0292","volume":"65","author":"I Fortier","year":"2001","unstructured":"Fortier I, Patry C, Lora M, Samadfan R, de Brum-Fernandes AJ: Immunohistochemical localization of the prostacyclin receptor (IP) human bone. Prostaglandins Leukot Essent Fatty Acids. 2001, 65: 79-83. 10.1054\/plef.2001.0292.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2375_CR63","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0303-7207(99)00210-5","volume":"160","author":"J Aubert","year":"2000","unstructured":"Aubert J, Saint-Marc P, Belmonte N, Dani C, Negrel R, Ailhaud G: Prostacyclin IP receptor up-regulates the early expression of C\/EBPbeta and C\/EBPdelta in preadipose cells. Mol Cell Endocrinol. 2000, 160: 149-156. 10.1016\/S0303-7207(99)00210-5.","journal-title":"Mol Cell Endocrinol"},{"key":"2375_CR64","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1124\/jpet.105.091967","volume":"315","author":"K Nakae","year":"2005","unstructured":"Nakae K, Saito K, Iino T, Yamamoto N, Wakabayashi M, Yoshikawa S, Matsushima S, Miyashita H, Sugimoto H, Kiba A, Gupta J: A prostacyclin receptor antagonist inhibits the sensitized release of substance P from rat sensory neurons. J Pharmacol Exp Ther. 2005, 315: 1136-1142. 10.1124\/jpet.105.091967.","journal-title":"J Pharmacol Exp Ther"},{"key":"2375_CR65","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1517\/14656566.5.7.1455","volume":"5","author":"G Petje","year":"2004","unstructured":"Petje G, Radler C, Aigner N, Manner H, Kriegs-Au G, Grill F: Pharmacological management of aseptic osteonecrosis in children. Expert Opin Pharmacother. 2004, 5: 1455-1462. 10.1517\/14656566.5.7.1455.","journal-title":"Expert Opin Pharmacother"},{"key":"2375_CR66","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/00003086-200105000-00006","volume":"386","author":"H Plenk Jr","year":"2001","unstructured":"Plenk H, Gstettner M, Grossschmidt K, Breitenseher M, Urban M, Hofmann S: Magnetic resonance imaging and histology of repair in femoral head osteonecrosis. Clin Orthop Relat Res. 2001, 386: 42-53. 10.1097\/00003086-200105000-00006.","journal-title":"Clin Orthop Relat Res"},{"key":"2375_CR67","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1302\/0301-620X.77B1.7822393","volume":"77","author":"ME Steinberg","year":"1995","unstructured":"Steinberg ME, Hayken GD, Steinberg DR: A quantitative system for staging avascular necrosis. J Bone Joint Surg Br. 1995, 77: 34-41.","journal-title":"J Bone Joint Surg Br"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2526.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar2526\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2526.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:33:44Z","timestamp":1728383624000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar2526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,3]]},"references-count":67,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2008,10]]}},"alternative-id":["2375"],"URL":"https:\/\/doi.org\/10.1186\/ar2526","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,3]]},"assertion":[{"value":"25 November 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R120"}}